DSGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 31.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,487,078.12

Design Therapeutics Insider Trading History Chart

Design Therapeutics Share Price & Price History

^$3.61

▼ -0.25 (-6.48%)

As of 04/1/2025 05:00 PM ET

Days: 30 | 90 | 365

Design Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/18/2024	Deepa Prasad	Director	Sell	3,806	$6.27	$23,863.62	20,000
8/9/2024	Arsani William	Director	Sell	814,874	$4.25	$3,463,214.50
3/25/2024	John P Schmid	Director	Buy	17,809	$3.74	$66,605.66	26,965
3/22/2024	John P Schmid	Director	Buy	9,156	$3.62	$33,144.72	9,156
9/29/2023	Rodney W Lappe	Director	Buy	21,000	$2.35	$49,350.00	133,024
8/29/2023	Deepa Prasad	Director	Buy	12,000	$2.31	$27,720.00	23,806
12/20/2022	Sr One Capital Fund I Aggregat	Major Shareholder	Buy	40,000	$8.14	$325,600.00	6,526,476
12/19/2022	Joao Md Siffert	CEO	Buy	1,150	$8.47	$9,740.50	126,319
12/19/2022	Simeon George	Director	Buy	360,000	$8.63	$3,106,800.00	6,486,476
12/16/2022	Simeon George	Director	Buy	500,000	$8.28	$4,140,000.00	6,126,476
12/9/2022	Rodney W Lappe	Director	Buy	15,000	$7.96	$119,400.00	112,024

See Full Table

SEC Filings (Institutional Ownership Changes) for Design Therapeutics (NASDAQ:DSGN)

56.64% of Design Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Design Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/18/2025	Frazier Life Sciences Management L.P.	1,953,547	$12.05M	0.5%	+3.2%	3.450%
2/17/2025	Squarepoint Ops LLC	48,186	$0.30M	0.0%	-43.4%	0.085%
2/17/2025	Two Sigma Advisers LP	233,900	$1.44M	0.0%	-23.3%	0.413%
2/17/2025	Two Sigma Investments LP	203,931	$1.26M	0.0%	-33.0%	0.360%
2/17/2025	Point72 Asset Management L.P.	1,856,750	$11.46M	0.0%	+16.0%	3.279%
2/17/2025	ProShare Advisors LLC	11,525	$71K	0.0%	N/A	0.020%
2/17/2025	MPM Bioimpact LLC	559,547	$3.45M	0.5%	N/A	0.988%
2/17/2025	Nuveen Asset Management LLC	158,004	$0.98M	0.0%	-25.7%	0.279%
2/17/2025	Jacobs Levy Equity Management Inc.	18,261	$0.11M	0.0%	-93.5%	0.032%
2/17/2025	D. E. Shaw & Co. Inc.	512,330	$3.16M	0.0%	-12.1%	0.905%
2/17/2025	Driehaus Capital Management LLC	776,082	$4.79M	0.0%	N/A	1.371%
2/17/2025	Bridgeway Capital Management LLC	128,400	$0.79M	0.0%	-45.5%	0.227%
2/17/2025	BNP Paribas Financial Markets	40,289	$0.25M	0.0%	N/A	0.071%
2/14/2025	Northern Trust Corp	388,125	$2.40M	0.0%	+15.2%	0.685%
2/14/2025	Dimensional Fund Advisors LP	215,265	$1.33M	0.0%	+60.2%	0.380%
2/13/2025	Walleye Capital LLC	141,127	$0.87M	0.0%	+101.6%	0.249%
2/13/2025	XTX Topco Ltd	48,424	$0.30M	0.0%	N/A	0.086%
2/13/2025	Barclays PLC	103,571	$0.64M	0.0%	+7.2%	0.183%
2/13/2025	Kennedy Capital Management LLC	14,266	$88K	0.0%	N/A	0.025%
2/13/2025	Renaissance Technologies LLC	253,500	$1.56M	0.0%	-7.5%	0.448%
2/13/2025	Invesco Ltd.	11,583	$71K	0.0%	N/A	0.020%
2/13/2025	Wells Fargo & Company MN	18,428	$0.11M	0.0%	+27.8%	0.033%
2/12/2025	Geode Capital Management LLC	761,640	$4.70M	0.0%	+0.4%	1.345%
2/12/2025	JPMorgan Chase & Co.	89,215	$0.55M	0.0%	+119.3%	0.158%
2/11/2025	Prudential Financial Inc.	56,315	$0.35M	0.0%	-4.7%	0.099%
2/11/2025	American Century Companies Inc.	39,115	$0.24M	0.0%	+19.9%	0.069%
2/11/2025	Intech Investment Management LLC	17,665	$0.11M	0.0%	N/A	0.031%
2/6/2025	Charles Schwab Investment Management Inc.	264,675	$1.63M	0.0%	+2.8%	0.467%
2/4/2025	Bank of New York Mellon Corp	95,348	$0.59M	0.0%	-3.8%	0.168%
1/30/2025	Palumbo Wealth Management LLC	54,696	$0.34M	0.1%	+48.7%	0.097%
1/30/2025	Rhumbline Advisers	52,932	$0.33M	0.0%	+4.7%	0.093%
1/24/2025	China Universal Asset Management Co. Ltd.	12,006	$74K	0.0%	N/A	0.021%
1/14/2025	Assenagon Asset Management S.A.	56,617	$0.35M	0.0%	-83.6%	0.100%
12/26/2024	JPMorgan Chase & Co.	40,687	$0.22M	0.0%	+186.9%	0.072%
11/20/2024	Virtu Financial LLC	46,356	$0.25M	0.0%	+318.8%	0.082%
11/19/2024	Barclays PLC	96,635	$0.52M	0.0%	+34.2%	0.171%
11/16/2024	Geode Capital Management LLC	758,550	$4.08M	0.0%	+7.1%	1.340%
11/15/2024	Frazier Life Sciences Management L.P.	1,892,547	$10.18M	0.4%	+58.3%	3.342%
11/15/2024	Barclays PLC	96,635	$0.52M	0.0%	+34.2%	0.171%
11/15/2024	Public Employees Retirement System of Ohio	8,272	$45K	0.0%	-63.1%	0.015%
11/15/2024	Jane Street Group LLC	24,003	$0.13M	0.0%	-58.5%	0.042%
11/15/2024	State Street Corp	690,826	$3.72M	0.0%	-0.7%	1.220%
11/15/2024	Point72 Asset Management L.P.	1,600,740	$8.61M	0.0%	+61.6%	2.827%
11/15/2024	Jacobs Levy Equity Management Inc.	280,271	$1.51M	0.0%	-41.2%	0.495%
11/15/2024	Baker BROS. Advisors LP	1,743,725	$9.38M	0.1%	+2.9%	3.080%
11/15/2024	Paloma Partners Management Co	11,902	$64K	0.0%	N/A	0.021%
11/14/2024	PDT Partners LLC	36,099	$0.19M	0.0%	+33.1%	0.064%
11/14/2024	Walleye Capital LLC	70,000	$0.38M	0.0%	+16.3%	0.124%
11/14/2024	MetLife Investment Management LLC	19,334	$0.10M	0.0%	N/A	0.034%
11/13/2024	Caz Investments LP	15,000	$81K	0.0%	-62.5%	0.026%
11/13/2024	FMR LLC	828,665	$4.46M	0.0%	+922.8%	1.464%
11/13/2024	The Manufacturers Life Insurance Company	13,221	$71K	0.0%	N/A	0.023%
11/12/2024	Charles Schwab Investment Management Inc.	257,432	$1.39M	0.0%	+43.0%	0.455%
11/5/2024	GSA Capital Partners LLP	173,744	$0.94M	0.1%	-17.2%	0.307%
10/28/2024	Palumbo Wealth Management LLC	36,774	$0.20M	0.1%	+11.3%	0.065%
10/3/2024	SG Americas Securities LLC	12,289	$66K	0.0%	N/A	0.022%
9/16/2024	Cubist Systematic Strategies LLC	23,497	$79K	0.0%	+75.6%	0.042%
8/19/2024	Point72 Asset Management L.P.	990,801	$3.32M	0.0%	+66.9%	1.754%
8/16/2024	Almitas Capital LLC	1,253,248	$4.20M	1.7%	+22.1%	2.218%
8/16/2024	Frazier Life Sciences Management L.P.	1,195,179	$4M	0.2%	N/A	2.116%
8/14/2024	Squarepoint Ops LLC	89,955	$0.30M	0.0%	+146.9%	0.159%
8/14/2024	Cubist Systematic Strategies LLC	23,497	$79K	0.0%	+75.6%	0.042%
8/14/2024	Marshall Wace LLP	24,280	$81K	0.0%	N/A	0.043%
8/12/2024	Hsbc Holdings PLC	44,470	$0.15M	0.0%	-8.9%	0.079%
8/9/2024	Renaissance Technologies LLC	384,075	$1.29M	0.0%	-15.3%	0.680%
8/9/2024	Dimensional Fund Advisors LP	80,953	$0.27M	0.0%	+119.7%	0.143%
8/8/2024	American Century Companies Inc.	21,333	$71K	0.0%	N/A	0.038%
8/6/2024	Acadian Asset Management LLC	583,160	$1.95M	0.0%	+44.5%	1.032%
7/26/2024	Bank of New York Mellon Corp	118,110	$0.40M	0.0%	+2.5%	0.209%
5/29/2024	Opaleye Management Inc.	113,038	$0.46M	0.1%	N/A	0.200%
5/16/2024	Jacobs Levy Equity Management Inc.	502,020	$2.02M	0.0%	-8.6%	0.889%
5/15/2024	Baker BROS. Advisors LP	1,662,120	$6.70M	0.1%	+10.8%	2.942%
5/15/2024	Public Employees Retirement System of Ohio	23,748	$96K	0.0%	-9.8%	0.042%
5/15/2024	Price T Rowe Associates Inc. MD	11,147	$45K	0.0%	N/A	0.020%
5/10/2024	Acadian Asset Management LLC	403,546	$1.63M	0.0%	+123.3%	0.714%
5/10/2024	Vanguard Group Inc.	1,285,962	$5.18M	0.0%	+29.0%	2.276%
5/9/2024	State Board of Administration of Florida Retirement System	12,630	$51K	0.0%	N/A	0.022%
5/8/2024	Bleakley Financial Group LLC	11,495	$46K	0.0%	N/A	0.020%
5/7/2024	SG Americas Securities LLC	11,316	$46K	0.0%	-40.0%	0.020%
5/3/2024	GSA Capital Partners LLP	216,347	$0.87M	0.1%	+199.3%	0.383%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	14,133	$57K	0.0%	N/A	0.025%
4/29/2024	Principal Financial Group Inc.	12,497	$50K	0.0%	-17.9%	0.022%
4/24/2024	Simplicity Wealth LLC	11,495	$46K	0.0%	N/A	0.020%
4/24/2024	Assenagon Asset Management S.A.	347,794	$1.40M	0.0%	+41.8%	0.616%
4/23/2024	BML Capital Management LLC	879,478	$3.54M	2.3%	-14.6%	1.557%
2/16/2024	Public Employees Retirement System of Ohio	26,338	$70K	0.0%	N/A	0.047%
2/14/2024	Pale Fire Capital SE	10,500	$28K	0.0%	N/A	0.019%
2/13/2024	Tower Research Capital LLC TRC	21,503	$57K	0.0%	+30.2%	0.038%
1/31/2024	Federated Hermes Inc.	11,999	$32K	0.0%	+317.6%	0.021%
1/30/2024	BML Capital Management LLC	1,029,478	$2.73M	2.1%	N/A	1.838%
1/25/2024	Nisa Investment Advisors LLC	11,560	$31K	0.0%	+38,433.3%	0.021%
11/15/2023	RTW Investments LP	2,512,986	$5.93M	0.1%	+60.8%	4.488%
11/14/2023	Corton Capital Inc.	27,134	$64K	0.0%	+56.6%	0.048%
11/14/2023	Prescott Group Capital Management L.L.C.	180,000	$0.43M	0.1%	N/A	0.321%
11/13/2023	Algert Global LLC	35,620	$84K	0.0%	+83.3%	0.064%
11/7/2023	Barclays PLC	71,678	$0.17M	0.0%	+353.1%	0.128%
11/7/2023	Jump Financial LLC	46,700	$0.11M	0.0%	+284.7%	0.083%
11/6/2023	Assenagon Asset Management S.A.	248,047	$0.59M	0.0%	-17.8%	0.443%
11/2/2023	Principal Financial Group Inc.	716,818	$1.69M	0.0%	-1.6%	1.280%
10/26/2023	Strs Ohio	72,800	$0.17M	0.0%	N/A	0.130%

Data available starting January 2016

See Full Table

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.

Today's Range

Now: $3.61

$3.46

$3.99

50 Day Range

MA: $4.67

$3.68

$5.33

52 Week Range

Now: $3.61

$3.15

$7.77

Volume

116,824 shs

Average Volume

211,966 shs

Market Capitalization

$204.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.77

Who are the company insiders with the largest holdings of Design Therapeutics?: Design Therapeutics' top insider shareholders include:
Rodney W Lappe (Director)
John P Schmid (Director)
Deepa Prasad (Director)
Arsani William (Director)
Learn More about top insider investors at Design Therapeutics.
Who are the major institutional investors of Design Therapeutics?: Design Therapeutics' top institutional shareholders include:
Frazier Life Sciences Management L.P. — 3.45%
Point72 Asset Management L.P. — 3.28%
Driehaus Capital Management LLC — 1.37%
Geode Capital Management LLC — 1.35%
MPM Bioimpact LLC — 0.99%
D. E. Shaw & Co. Inc. — 0.90%
Learn More about top institutional investors of Design Therapeutics stock.
Which major investors are selling Design Therapeutics stock?: Within the last quarter, DSGN stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Jacobs Levy Equity Management Inc.
Bridgeway Capital Management LLC
Two Sigma Investments LP
Two Sigma Advisers LP
D. E. Shaw & Co. Inc.
Nuveen Asset Management LLC
Squarepoint Ops LLC
In the previous year, company insiders that have sold Design Therapeutics company stock include:
Rodney W Lappe (Director)
John P Schmid (Director)
Learn More investors selling Design Therapeutics stock.
Which major investors are buying Design Therapeutics stock?: In the previous quarter, DSGN stock was bought by institutional investors including:
Driehaus Capital Management LLC
MPM Bioimpact LLC
Point72 Asset Management L.P.
Dimensional Fund Advisors LP
Walleye Capital LLC
Frazier Life Sciences Management L.P.
Northern Trust Corp
JPMorgan Chase & Co.
Within the previous year, these company insiders have bought Design Therapeutics stock:
Rodney W Lappe (Director)
John P Schmid (Director)
Deepa Prasad (Director)
Learn More investors buying Design Therapeutics stock.